143 related articles for article (PubMed ID: 38627926)
1. Initial outcomes and surgical techniques of prostatic urethral lift for benign prostatic hyperplasia in Japan.
Anan G; Kaga K; Fujishima Y; Minami H; Mueller T; Sussman D
Int J Urol; 2024 Apr; ():. PubMed ID: 38627926
[TBL] [Abstract][Full Text] [Related]
2. Medium-Term Real-World Outcomes of Minimally Invasive Surgical Therapies for Benign Prostatic Hyperplasia: Water Vapor Thermal Therapy (Rezum)
Chin CP; Garden EB; Ravivarapu KT; Shukla D; Omidele O; Levy M; Qian D; Araya JS; Valenzuela R; Reddy A; Marshall S; Motola J; Nobert C; Gupta M; Small AC; Kaplan SA; Palese MA
J Endourol; 2022 Dec; 36(12):1559-1566. PubMed ID: 36039926
[No Abstract] [Full Text] [Related]
3. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.
Sievert KD; Schonthaler M; Berges R; Toomey P; Drager D; Herlemann A; Miller F; Wetterauer U; Volkmer B; Gratzke C; Amend B
World J Urol; 2019 Jul; 37(7):1353-1360. PubMed ID: 30283994
[TBL] [Abstract][Full Text] [Related]
4. Improvement in International Prostate Symptom Score after prostatic urethral lifts is dependent on prostatic volume.
Patel SR; Lowrey KA; Johny A; Smith CP
Can J Urol; 2023 Aug; 30(4):11619-11623. PubMed ID: 37633290
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of minimally invasive surgical treatments for benign prostatic hyperplasia: implications for Japan's public healthcare system.
Anezaki H; Endo F; Swan G; Takashima K; Rojanasarot S
J Med Econ; 2024; 27(1):554-565. PubMed ID: 38466193
[TBL] [Abstract][Full Text] [Related]
6. Initial experience with prostatic urethral lift versus enucleation of the prostate: a retrospective comparative study.
Obinata D; Uehara R; Hashimoto S; Nakahara K; Yoshizawa T; Mochida J; Yamaguchi K; Takahashi S
BMC Urol; 2023 Nov; 23(1):188. PubMed ID: 37980529
[TBL] [Abstract][Full Text] [Related]
7. Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH; Reddy B; McCutcheon KA; Borofsky M; Narayan V; Kim MH; Dahm P
Cochrane Database Syst Rev; 2019 May; 5(5):CD012832. PubMed ID: 31128077
[TBL] [Abstract][Full Text] [Related]
8. A Systematic Review and Meta-analysis of Prostatic Urethral Lift for Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Xiang P; Wang M; Guan D; Liu D; Wang Y; Hao Y; Li S; Liu Y; Ping H
Eur Urol Open Sci; 2020 Jul; 19():3-15. PubMed ID: 34337448
[TBL] [Abstract][Full Text] [Related]
9. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.
Roehrborn CG; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Brown BT; McVary KT; Te AE; Gholami SS; Rashid P; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rukstalis DB
J Urol; 2013 Dec; 190(6):2161-7. PubMed ID: 23764081
[TBL] [Abstract][Full Text] [Related]
10. Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis.
Perera M; Roberts MJ; Doi SA; Bolton D
Eur Urol; 2015 Apr; 67(4):704-13. PubMed ID: 25466940
[TBL] [Abstract][Full Text] [Related]
11. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
[TBL] [Abstract][Full Text] [Related]
12. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study.
Roehrborn CG; Barkin J; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Cantwell AL; McVary KT; Te AE; Gholami SS; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Herron S; Rashid P; Rukstalis DB
Can J Urol; 2017 Jun; 24(3):8802-8813. PubMed ID: 28646935
[TBL] [Abstract][Full Text] [Related]
13. 24-month durability after crossover to the prostatic urethral lift from randomised, blinded sham.
Rukstalis D; Rashid P; Bogache WK; Tutrone RF; Barkin J; Chin PT; Woo HH; Cantwell AL; Cowan BE; Bolton DM
BJU Int; 2016 Oct; 118 Suppl 3():14-22. PubMed ID: 27684483
[TBL] [Abstract][Full Text] [Related]
14. Prostatic Urethral Lift for Obstructive Median Lobes: Consistent Results Across Controlled Trial and Real-World Settings.
Eure G; Rukstalis D; Roehrborn C
J Endourol; 2023 Jan; 37(1):50-59. PubMed ID: 35876440
[No Abstract] [Full Text] [Related]
15. Temporarily implanted nitinol device versus prostatic urethral lift for minimally invasive surgical treatment of benign prostatic hyperplasia with lower urinary tract symptoms: a matching-adjusted indirect comparison.
Kernen KM; Omar S; Goodnight B; Skodny P; Bruce S; Yu TM
Can J Urol; 2023 Oct; 30(5):11676-11685. PubMed ID: 37838995
[TBL] [Abstract][Full Text] [Related]
16. Early patient experience following treatment with the UroLift prostatic urethral lift and Rezum steam injection.
Tutrone RF; Schiff W
Can J Urol; 2020 Jun; 27(3):10213-10219. PubMed ID: 32544043
[TBL] [Abstract][Full Text] [Related]
17. Urethral lift for benign prostatic hyperplasia: a comprehensive review of the literature.
Larcher A; Broglia L; Lughezzani G; Mistretta F; Abrate A; Lista G; Fossati N; Sangalli M; Kuefner D; Cestari A; Buffi N; Lazzeri M; Guazzoni G; Montorsi F
Curr Urol Rep; 2013 Dec; 14(6):620-7. PubMed ID: 23794125
[TBL] [Abstract][Full Text] [Related]
18. Three year results of the prostatic urethral L.I.F.T. study.
Roehrborn CG; Rukstalis DB; Barkin J; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Cantwell AL; McVary KT; Te AE; Gholami SS; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rashid P
Can J Urol; 2015 Jun; 22(3):7772-82. PubMed ID: 26068624
[TBL] [Abstract][Full Text] [Related]
19. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.
Franco JV; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013656. PubMed ID: 34693990
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore.
Chay J; Tung JYM; Su RJ; Aslim EJ; Wong C; Swan G; Chua WJ; Ho HSS; Finkelstein EA
J Med Econ; 2023; 26(1):1269-1277. PubMed ID: 37800562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
